Investing Profile

Greg Yap

InvestorVC

Partner at Menlo Ventures

menlovc.com/greg-yapPalo Alto, California
Photo of Greg Yap, Partner at Menlo Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$8.0M - $15.0M
$12.0M
15
$500M
CompanyStageDateRound SizeTotal Raised
Clear Labs
Series CMay 2021$60M
Venture RoundMay 2020$21M
Series BOct 2018$21M
$120M
Co-investors: Aydin Senkut (Felicis Ventures), Krishna Yeshwant (GV), Kyle Kurpinski (Tencent Holdings)
Ophelia
Series AApr 2021$15M
$65M
Co-investors: Jay Chen (Tiger Global Management), Elliott Cohen
Riva Health
Venture RoundMar 2021$16M
$16M
Delfi Diagnostics
Series AJan 2021$100M
$100M
Co-investors: Rishi Gupta (OrbiMed)
Earli
Series AJan 2021$40M
Seed RoundSep 2018$20M
$60M
Co-investors: Ursheet Parikh (Mayfield), Marc Andreessen (Andreessen Horowitz), Vinod Khosla (Khosla Ventures), Jorge Conde (Andreessen Horowitz), Deep Nishar (General Catalyst), Matt Murphy (Menlo Ventures), Anna Fang (ZhenFund), Lee Linden (Quiet Capital), Jack Abraham (Atomic), Ramtin Naimi (Abstract Ventures)
Genesis Therapeutics
Series ADec 2020$52M
$56M
Co-investors: Vijay Pande (Andreessen Horowitz), Miriam Rivera (Ulu Ventures), Clint Korver (Ulu Ventures), Bukola Ojo
Encoded Therapeutics
Series DJul 2020$140M
Series CJun 2019$100M
$240M
Co-investors: David Schenkein (GV)
Particle Health
Series AApr 2020$12M
$37M
Co-investors: Rebecca Lynn (Canvas Ventures)